Supraventricular tachyarrhythmias during the intrauterine, neonatal and infant period: A 10 ‐year population‐based study
ConclusionThe prognosis of SVT in the first year of life is good: with optimized pharmacological treatment the need for early catheter ablation and mortality rate are low (< 1%) and there is a high rate of spontaneous arrhythmia resolution. Heart failure is a possible predictor of arrhythmia persistence with need for ablation in later life.This article is protected by copyright. All rights reserved
Source: Pacing and Clinical Electrophysiology : PACE - Category: Cardiology Authors: Marko Bjelo ševič,
Viera Illíková,
Jaroslav Tomko,
Peter Olejník,
Michal Chalupka,
Robert Hatala Tags: ELECTROPHYSIOLOGY Source Type: research
More News: Amiodarone | Arrhythmia | Cardiology | Heart | Heart Disease | Heart Failure | Perinatology & Neonatology | Slovakia Health | Study